Medical Director, Advanced Cardiac Therapies ICU Children's Hospital of Philadelphia Philadelphia, Pennsylvania
Disclosure(s):
Aaron DeWitt: No relevant financial relationship(s) to disclose.
This session will review the role of lymphatic conduction disorders, both congenital and acquired, in pediatric critical illness and highlight novel therapeutic options.
Learning Objectives:
Discuss the contribution of disordered lymphatic conduction to pediatric respiratory failure and other critical illnesses
Recall recent advances in lymphatic pharmacogenetics that directly inform novel therapeutic options.
Explain the rationale, implementation, and outcomes for mechanical lymphatic diversion and autotransfusion as novel therapies
